AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
HIV incidence estimates among women of childbearing age in the area aroundParis, France: No evidence for any effect of age or time
Authors: Goubar, A Costagliola, D
Citation: A. Goubar et D. Costagliola, HIV incidence estimates among women of childbearing age in the area aroundParis, France: No evidence for any effect of age or time, J ACQ IMM D, 27(5), 2001, pp. 492-498
Primary prevention with cotrimoxazole for HIV-1-infected adults: Results of the pilot study in Dakar, Senegal
Authors: Maynart, M Lievre, L Sow, PS Kony, S Gueye, NFN Bassene, E Metro, A Ndoye, I Ba, DS Coulaud, JP Costagliola, D
Citation: M. Maynart et al., Primary prevention with cotrimoxazole for HIV-1-infected adults: Results of the pilot study in Dakar, Senegal, J ACQ IMM D, 26(2), 2001, pp. 130-136
Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis
Authors: Abgrall, S Matheron, S Le Moing, V Dupont, C Costagliola, D
Citation: S. Abgrall et al., Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis, J ACQ IMM D, 26(2), 2001, pp. 151-158
The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system
Authors: Calvez, T Biou, M Costagliola, D Jullien, AM Laurian, Y Rossi, F Rothschild, C Sie, P
Citation: T. Calvez et al., The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system, HAEMOPHILIA, 7(1), 2001, pp. 82-88
Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era
Authors: Abgrall, S Rabaud, C Costagliola, D
Citation: S. Abgrall et al., Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era, CLIN INF D, 33(10), 2001, pp. 1747-1755
HIV type 1-specific IgG2 antibodies: Markers of helper T cell type 1 response and prognostic marker of long-term nonprogression
Authors: Ngo-Giang-Huong, N Candotti, D Goubar, A Autran, B Maynart, M Sicard, D Clauvel, JP Agut, H Costagliola, D Rouzioux, C
Citation: N. Ngo-giang-huong et al., HIV type 1-specific IgG2 antibodies: Markers of helper T cell type 1 response and prognostic marker of long-term nonprogression, AIDS RES H, 17(15), 2001, pp. 1435-1446
Adjunction of polymerase chain reaction in screening for hepatitis C virusRNA in blood donations: misuse of the principle of caution
Authors: Loubiere, S Rotily, M Durand-Zaleski, I Costagliola, D Moatti, JP
Citation: S. Loubiere et al., Adjunction of polymerase chain reaction in screening for hepatitis C virusRNA in blood donations: misuse of the principle of caution, M S-MED SCI, 17(3), 2001, pp. 344-349
The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia.
Authors: Ducimetiere, P Signeyrole, D Giral, P Hoog-Labouret, N Amarenco, P Chanu, B Chauvenet, M Coletti, M Dallongeville, J Durlach, V Kawka, G Krempf, M Leroux, G Mlika-Cabanne, N Monnier, L Paillard, F Rostoker, G Sicard, D Verny, C Voiriot, P Acquart, B Alquier, G Ankri, J Badoc, G Basdevant, A Belmin, J Berthezene, F Beucler, I Blanc, F Broustet, JP Bruckert, E Brun, JM Castaigne, A Charpentier, JM Andre, MC Cogneau, J Demeaux, JL Denolle, T Desson, JF Drahi, E Drouin, P Dumel, F Emmerich, J Farnier, M Fontbonne, A Forette, B Gambert, P Gautier, JC Guillausseau, PJ Hommel, M Janowski, M Le Goaziou, MF Lievre, M Le Quere, M Leys, D Marechaud, R Mas, JL Menard, J Michel, JM Mounier-Vehier, F Mottier, D Passa, P Pinel, JF Puel, J Raccah, D Renou, P Ribier, A Schlienger, JL Thomas, D Vallee, JP Veyssier-Belot, C Bouvenot, G Abadie, E Alexandre, JM Belorgey-Bismut, C Bergmann, JF Camelli, B Caulin, C Costagliola, D Denis, C Dupuis, B Fleurette, F Guillevin, L Hoog-Labouret, N Paintaud, G Rauss, A Poynard, T Rostoker, G Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study
Authors: Duran, S Solas, C Spire, B Carrieri, MP Fuzibet, JG Costagliola, D Lacarelle, B Moatti, JP
Citation: S. Duran et al., 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, 15(8), 2001, pp. 1075-1077
Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study
Authors: Serfaty, L Costagliola, D Wendum, D Picard, O Meyohas, MC Girard, PM Lebas, J Delamare, C Poupon, R Housset, C
Citation: L. Serfaty et al., Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study, AIDS, 15(15), 2001, pp. 2011-2016
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study
Authors: Descamps, D Calvez, V Izopet, J Bluffet-Janvresse, C Schmuck, A Colson, P Ruffault, A Maillard, A Masquelier, B Cottalorda, J Harzic, M Brun-Vezinet, F Costagliola, D
Citation: D. Descamps et al., Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study, AIDS, 15(14), 2001, pp. 1777-1782
Including polymerase chain reaction in screening for hepatitis C virus RNAin blood donations is not cost-effective
Authors: Loubiere, S Rotily, M Durand-Zaleski, I Costagliola, D
Citation: S. Loubiere et al., Including polymerase chain reaction in screening for hepatitis C virus RNAin blood donations is not cost-effective, VOX SANGUIN, 80(4), 2001, pp. 199-204
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Authors: Besson, C Goubar, A Gabarre, J Rozenbaum, W Pialoux, G Chatelet, FP Katlama, C Charlotte, F Dupont, B Brousse, N Huerre, M Mikol, J Camparo, P Mokhtari, K Tulliez, M Salmon-Ceron, D Boue, F Costagliola, D Raphael, M
Citation: C. Besson et al., Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy, BLOOD, 98(8), 2001, pp. 2339-2344
Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy
Authors: Kazatchkine, MD Van, PN Costagliola, D Mohammed, AS Ledeine, JM Troccaz, M Belec, L
Citation: Md. Kazatchkine et al., Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy, J ACQ IMM D, 24(5), 2000, pp. 418-424
HIV-1 quantitive dynamics in vivo: a review of mathematical models
Authors: Le Corfec, E Rouzioux, C Costagliola, D
Citation: E. Le Corfec et al., HIV-1 quantitive dynamics in vivo: a review of mathematical models, REV EPIDEM, 48(2), 2000, pp. 168-181
Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993
Authors: Bernillon, P Lievre, L Pillonel, J Laporte, A Costagliola, D
Citation: P. Bernillon et al., Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993, INT J EPID, 29(1), 2000, pp. 168-174
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy
Authors: Salmon-Ceron, D Mazeron, MC Chaput, S Boukli, N Senechal, R Houhou, N Katlama, C Matheron, S Fillet, AM Gozlan, J Leport, C Jeantils, V Freymuth, F Costagliola, D
Citation: D. Salmon-ceron et al., Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1041-1049
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients
Authors: Anduze-Faris, BM Fillet, AM Gozlan, J Lancar, R Boukli, N Gasnault, J Caumes, E Livartowsky, J Matheron, S Leport, C Salmon, D Costagliola, D Katlama, C
Citation: Bm. Anduze-faris et al., Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients, AIDS, 14(5), 2000, pp. 517-524
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor
Authors: Grabar, S Pradier, C Le Corfec, E Lancar, R Allavena, C Bentata, M Berlureau, P Dupont, C Fabbro-Peray, P Poizot-Martin, I Costagliola, D
Citation: S. Grabar et al., Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor, AIDS, 14(2), 2000, pp. 141-149
Rapid progression to AIDS in HIV+ individuals with a structural variant ofthe chemokine receptor CX(3)CR1
Authors: Faure, S Meyer, L Costagliola, D Vaneensberghe, C Genin, E Autran, B Delfraissy, JF McDermott, DH Murphy, PM Debre, P Theodorou, I Combadiere, C
Citation: S. Faure et al., Rapid progression to AIDS in HIV+ individuals with a structural variant ofthe chemokine receptor CX(3)CR1, SCIENCE, 287(5461), 2000, pp. 2274-2277
Clinical outcome of patients with HIV-1 infection according to immunologicand virologic response after 6 months of highly active antiretroviral therapy
Authors: Grabar, S Le Moing, V Goujard, C Leport, C Kazatchkine, MD Costagliola, D Weiss, L
Citation: S. Grabar et al., Clinical outcome of patients with HIV-1 infection according to immunologicand virologic response after 6 months of highly active antiretroviral therapy, ANN INT MED, 133(6), 2000, pp. 401-410
Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors
Authors: Candotti, D Calvez, V Autran, B Costagliola, D Rouzioux, C Agut, H
Citation: D. Candotti et al., Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors, J ACQ IMM D, 21(3), 1999, pp. 253-255
Risk-benefit analysis of Nucleic Acid Testing: The French experience
Authors: Saura, C Courouce, AM Pillonel, J Costagliola, D Flan, B Defer, C Coste, J Rouzioux, C
Citation: C. Saura et al., Risk-benefit analysis of Nucleic Acid Testing: The French experience, BIOLOGICALS, 27(4), 1999, pp. 343-348
In vitro endothelialization of PTFE vascular grafts: A comparison of various substrates, cell densities, and incubation times
Authors: Vinard, E Leseche, G Andreassian, B Costagliola, D
Citation: E. Vinard et al., In vitro endothelialization of PTFE vascular grafts: A comparison of various substrates, cell densities, and incubation times, ANN VASC S, 13(2), 1999, pp. 141-150
Is the AIDS incubation time changing? A back-calculation approach
Authors: Deuffic, S Costagliola, D
Citation: S. Deuffic et D. Costagliola, Is the AIDS incubation time changing? A back-calculation approach, STAT MED, 18(9), 1999, pp. 1031-1047
Risultati: 1-25 | 26-35